poisar

Stocks · News reference

BMO Capital Maintains Buy Rating and $518 Price Target on Intuitive Surgical

Fiscal.ai

BMO Capital analyst Vik Chopra reaffirmed a 'Buy' rating and a $518 price target for Intuitive Surgical (ISRG).

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolThe Rule Breakers Team

    Fools Stay Optimistic in the Face of Fear

    Following a significant market sell-off where the Nasdaq-100 fell 6.36% on Thursday, the index rebounded 3.40% on Monday. The article advocates for maintaining an optimistic, long-term investment approach during market downturns, emphasizing that patient investors who continue buying through dips have historically benefited. Historical examples include Intuitive Surgical rising 53-fold since 2006 and MercadoLibre rising more than fivefold since 2009 when purchased during market corrections.

  2. Zacks Investment ResearchZacks.Com

    RVTY Q3 Earnings Beat Estimates on Life Sciences Strength, '26 View Up

    Revvity (RVTY) reported Q3 2026 adjusted EPS of $1.38, beating estimates by 7%, with revenues rising 4.3% to $728.9M. Life Sciences revenues climbed 10.7% driven by strong pharma and biotech demand. The company raised its 2026 pro forma EPS guidance to $5.40-$5.45 and revenue forecast to $2.86B, reflecting 6% total growth and 5% organic growth.